Promising clinical results from use of Episealer® accepted for presentation at annual meeting of the Australian Knee Society
Episurf Medical (NASDAQ: EPIS B) today announces that the scientific abstract “Clinical results of an individualized mini-metal implant for focal cartilage lesions in the knee” by Ass. Prof. Karl Eriksson et al. has been accepted for presentation at the annual congress of the Australian Knee Society (AKS). The congress will take place in Broome, Australia on October 11-13, 2018. The abstract focuses on interim results from a European multicenter study with the Episealer® knee implant. The results will be presented by Ass. Prof. Karl Eriksson from Stockholm South General Hospital, Sweden.